Jimmy Narayan
Overview
Explore the profile of Jimmy Narayan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
111
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Venkatesh V, Pati G, Uthansingh K, Mallick P, Narayan J, Mishra D, et al.
J Clin Exp Hepatol
. 2023 Jan;
13(1):31-36.
PMID: 36647417
Background/aims: In view of limited data on the knowledge and awareness of hepatitis B virus (HBV) and the available preventive strategies at the community level, it was aimed to analyse...
12.
Behera M, Narayan J, Sahu M, Behera S, Singh A, Mishra D, et al.
Middle East J Dig Dis
. 2023 Jan;
13(3):216-222.
PMID: 36606224
BACKGROUND Left ventricular diastolic dysfunction (LVDD) is the earliest cardiac dysfunction noted in patients with liver cirrhosis, which increases the morbidity and mortality in such patients. There are sparse studies...
13.
Nittala R, Behera M, Sahu M, Narayan J, Mishra D, Panda A, et al.
Indian J Tuberc
. 2022 Dec;
69(4):690-694.
PMID: 36460409
Abdominal tuberculosis is one of the common extra pulmonary tuberculosis with diverse clinical manifestations. It has high disease burden in endemic countries like India leading to significant morbidity and mortality...
14.
Behera M, Swain S, Sahu M, Behera G, Mishra D, Narayan J, et al.
Int J Hepatol
. 2021 Dec;
2021:5592376.
PMID: 34900353
Background: Left ventricular diastolic dysfunction (LVDD) appears to be the earliest cardiac disturbance in cirrhosis patients. There are many previous reports reporting the significance of severity of LVDD on the...
15.
Valantine B, Sundaray N, Mishra D, Sahu S, Narayan J, Panda B, et al.
JGH Open
. 2021 Jun;
5(6):686-694.
PMID: 34124387
Background And Aim: Acute-on-chronic liver failure (ACLF) is a transpiring entity, which possesses high short-term/early mortality (28 days). Several mortality predictors have been studied, but none were proved reliable. Serum...
16.
Jena S, Pati G, Uthansingh K, Venkatesh G, Mallick P, Behera M, et al.
Cureus
. 2021 May;
13(4):e14427.
PMID: 33996293
Background and aim Idiopathic chronic pancreatitis (ICP) is said to be present when no identifiable etiology can be identified. Robust evidence suggested that the serine protease inhibitor nucleus Kazol type...
17.
Behera M, Pati G, Narayan J, Mishra D, Meher L, Singh A, et al.
J Clin Exp Hepatol
. 2021 Mar;
11(1):37-44.
PMID: 33679047
Background And Aim: Chronic Hepatitis B (CHB) is a global health problem affecting around 400 million of people worldwide. Two available first-line antiviral drugs are tenofovir disoproxil fumarate (TDF) and...
18.
Pati G, Kar C, Narayan J, Uthansingh K, Behera M, Sahu M, et al.
Cureus
. 2021 Feb;
13(1):e12692.
PMID: 33614302
Introduction: Irritable bowel syndrome (IBS) is a common gastrointestinal (GI) disorder. Female patients with bowel disease commonly report worsening of symptoms in the menstrual cycle. However, there is a paucity...
19.
Nath P, Panigrahi M, Sahu M, Narayan J, Sahoo R, Patra A, et al.
J Clin Transl Hepatol
. 2020 Aug;
8(2):120-126.
PMID: 32832391
Lifestyle (exercise and dietary) modification is the mainstay of treatment for non-alcoholic fatty liver disease (NAFLD). However, there is paucity of data on effect of intensity of exercise in management...
20.
Narayan J, Das H, Nath P, Singh A, Mishra D, Padhi P, et al.
Int J Hepatol
. 2020 Jul;
2020:1825142.
PMID: 32724678
Background: The study was designed to assess cardiovascular risk factors flow-mediated dilatation % (FMD%) and carotid intima-media thickness (CIMT) in NAFLD. Methods: 126 NAFLD subjects and 31 chronic hepatitis B...